Is AstraZeneca looking for the ideal candidate to replace Pascal Soriot?
You can expect to hear plenty of new rumors about Pascal Soriot’s impending departure from AstraZeneca’s helm — whether they’re true or not.
A year after Soriot rather slowly refuted a host of press reports that he was considering a jump to the helm at Teva, The Sunday Times reported over the weekend that AstraZeneca has begun succession planning following shareholder pressure as the pharma giant works to achieve a turnaround. They’ll also reportedly be looking for someone to succeed chief financial officer Marc Dunoyer as well.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.